Article
Cumplimiento de las metas del ATPIII con los diferentes tratamientos hipolipemiantes en centros hospitalarios de Quito y Guayaquil
Fecha
2016-09Autor
Estrella, Andrea
Hernández, Isabel
Salazar, Jorge
Duarte, Yan
Terán, Enrique
Institución
Resumen
Cardiovascular diseases cause avoidable health care costs; therefore the panel of experts on Detection, Evaluation and Treatment of High Cholesterol (ATPIII) has established guidelines for its treatment. In this explanatory, observational and retrospective study, 195 patients were studied, both in public and private sectors, adults older than 30 years, with confirmed dyslipidemia by laboratory analysis; who have received medical care for at least three months. From each patient
clinical record, age, gender, diagnosis, initial and 12 weeks values of lipids, and treatment provided were collected. The results showed that subjects had high or very high cardiovascular risk, also they were mainly female. Comparing the initial with the post treatment lipid values, in the high-risk group there was a no significant decrease in all lipids values, whereas in very high risk subjects there was a significant decrease of triglycerides (p=0.02) and LDL cholesterol (p<0.0001). The achievement of ATP III goals was only in 20% subjects. Statins were the treatment of choice in 91% of the cases.